drugset / Trial / NCT00003262
Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of two combination chemotherapy regimens in treating patients with Hodgkin's disease and HIV infection.
Timeline
- Start
- 1997-05
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bleomycin | Unknown | — | Intramuscular |
| Subject | Doxorubicin | Other / unclassified | — | Intravenous |
| Subject | Epirubicin | Small molecule | — | Intravenous |
| Subject | Etoposide | Small molecule | — | Intravenous |
| Subject | Prednisone | Other / unclassified | — | Oral |
| Subject | Vinblastine | Small molecule | — | Intravenous |
| Subject | Vincristine | Small molecule | — | Intravenous |
| Subject | mechlorethamine | Small molecule | — | Intravenous |
| Background | filgrastim | Protein / enzyme biologic | — | — |